Based on the Cutera Inc stock forecast from 0 analysts, the average analyst target price for Cutera Inc is not available over the next 12 months. Cutera Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Cutera Inc is Very Bearish, which is based on 0 positive signals and 10 negative signals. At the last closing, Cutera Inc’s stock price was USD 0.10. Cutera Inc’s stock price has changed by +0.00% over the past week, -17.04% over the past month and -93.79% over the last year.
No recent analyst target price found for Cutera Inc
No recent average analyst rating found for Cutera Inc
Company Overview Cutera Inc
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California. On March 5, 2025, Cutera, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas. Read Less
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClea...Read More
Frequently Asked Questions About Cutera Inc (CUTR) Stock
Stock Target Advisor's fundamental analysis for Cutera Inc's stock is Very Bearish.
Unfortunately we do not have enough data on CUTR's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on CUTR's stock to indicate what its average analyst target is.
CUTR stock's Price/Earning ratio is 472.91.
Our analysis grades CUTR stock's Price / Earning ratio at F. This means that CUTR stock's Price/Earning ratio is above 98% of the stocks in the Medical Devices sector in the OTC exchange.
Based on this CUTR may be a overvalued for its sector.
The last closing price of CUTR's stock was USD 0.10.
The most recent market capitalization for CUTR is USD 1.96M.
Unfortunately we do not have enough analyst data on CUTR's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Cutera Inc's stock.
As per our most recent records Cutera Inc has 430 Employees.
Cutera Inc's registered address is 3240 Bayshore Boulevard, Brisbane, CA, United States, 94005-1021.
You can get more information about it from Cutera Inc's website at https://www.cutera.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Cutera Inc (CUTR) Stock
Stock Target Advisor's fundamental analysis for Cutera Inc's stock is Very Bearish.
Unfortunately we do not have enough data on CUTR's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on CUTR's stock to indicate what its average analyst target is.
CUTR stock's Price/Earning ratio is 472.91.
Our analysis grades CUTR stock's Price / Earning ratio at F. This means that CUTR stock's Price/Earning ratio is above 98% of the stocks in the Medical Devices sector in the OTC exchange.
Based on this CUTR may be a overvalued for its sector.
The last closing price of CUTR's stock was USD 0.10.
The most recent market capitalization for CUTR is USD 1.96M.
Unfortunately we do not have enough analyst data on CUTR's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Cutera Inc's stock.
As per our most recent records Cutera Inc has 430 Employees.
Cutera Inc's registered address is 3240 Bayshore Boulevard, Brisbane, CA, United States, 94005-1021.
You can get more information about it from Cutera Inc's website at https://www.cutera.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CUTR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
